{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:03:41Z","timestamp":1792145021143,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100024158","name":"ARS Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024158","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jaip.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:19:16Z","timestamp":1770826756000},"page":"837-845.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetics and Pharmacodynamics Following Repeat Dosing of neffy (Epinephrine Nasal Spray) Versus Intramuscular Injection During Induced Allergic Rhinitis"],"prefix":"10.1016","volume":"14","author":[{"given":"John","family":"Oppenheimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Casale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Spergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Carlos A.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lowenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.02.005_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.anai.2015.07.019","article-title":"Anaphylaxis\u2013a practice parameter update 2015","volume":"115","author":"Lieberman","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.02.005_bib2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis\u2014a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.005_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/all.15032","article-title":"European Academy of Allergy and Clinical Immunology, Food Allergy, Anaphylaxis Guidelines Group. EAACI guidelines: Anaphylaxis (2021 update)","volume":"77","author":"Muraro","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.02.005_bib4","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaci.2021.03.042","article-title":"Use of multiple epinephrine doses in anaphylaxis: a systematic review and meta-analysis","volume":"148","author":"Patel","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.005_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/10903127.2017.1402110","article-title":"Pediatric anaphylaxis in the prehospital setting: incidence, characteristics, and management","volume":"22","author":"Andrew","year":"2018","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.jaip.2026.02.005_bib6","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.jaci.2016.02.016","article-title":"Increasing visits for anaphylaxis and the benefits of early epinephrine administration: a 4-year study at a pediatric emergency department in Montreal, Canada","volume":"137","author":"Hochstadter","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.005_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaip.2014.07.004","article-title":"Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization","volume":"3","author":"Fleming","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.005_bib8","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jaip.2019.10.027","article-title":"Biphasic reactions in emergency department anaphylaxis patients: a prospective cohort study","volume":"8","author":"Liu","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.005_bib9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.005_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaci.2013.08.016","article-title":"Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States","volume":"133","author":"Wood","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.005_bib11","series-title":"neffy epinephrine nasal spray USP. Prescription Information. ARS Pharmaceuticals Operations","year":"2025"},{"key":"10.1016\/j.jaip.2026.02.005_bib12","article-title":"Prescription Information","year":"2023","journal-title":"Mylan Specialty L.P"},{"key":"10.1016\/j.jaip.2026.02.005_bib14","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jaci.2023.08.007","article-title":"Pharmacokinetics\/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection","volume":"152","author":"Casale","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.005_bib15","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.jaip.2024.02.038","article-title":"Upper respiratory tract infections have minimal impact on neffy\u2019s pharmacokinetics or pharmacodynamics","volume":"12","author":"Oppenheimer","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.005_bib16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaip.2023.11.006","article-title":"Adult pharmacokinetics of self-administration of epinephrine nasal spray 2.0 mg versus manual intramuscular epinephrine 0.3 mg by health care providers","volume":"12","author":"Casale","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.005_bib17","first-page":"4","article-title":"The impact of anaphylaxis on the absorption of intranasal epinephrine in anaesthetized non-na\u00efve beagle dogs","volume":"2","author":"Sparapani","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaip.2026.02.005_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics16060811","article-title":"Development of neffy, an epinephrine nasal spray, for severe allergic reactions","volume":"16","author":"Ellis","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jaip.2026.02.005_bib19","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.jaip.2025.06.038","article-title":"Epinephrine nasal spray improves allergic symptoms in patients undergoing oral food challenge, phase 3 trial","volume":"13","author":"Ebisawa","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.005_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13223-015-0082-0","article-title":"The Allergic Rhinitis\u2013Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies","volume":"11","author":"Ellis","year":"2015","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.005_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.anai.2018.02.009","article-title":"Repeatability of nasal allergen challenge results: further validation of the allergic rhinitis clinical investigator collaborative protocols","volume":"120","author":"Soliman","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.02.005_bib22","article-title":"Should a second dose of epinephrine be injected into the opposite thigh?","author":"Sicherer","year":"2019","journal-title":"Allergic Living"},{"key":"10.1016\/j.jaip.2026.02.005_bib23","series-title":"Allergic rhinitis: developing drug products for treatment [guidance for industry]","year":"2018"},{"key":"10.1016\/j.jaip.2026.02.005_bib24","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/cea.12974","article-title":"Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: a randomized trial","volume":"47","author":"Ellis","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2026.02.005_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5414\/CP201825","article-title":"Impact of allergic rhinitis and its treatment on the pharmacokinetics of nasally administered fentanyl","volume":"51","author":"Perelman","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2026.02.005_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12931-020-01343-x","article-title":"Intranasal epinephrine effects on epinephrine pharmacokinetics and heart rate in a nasal congestion canine model","volume":"21","author":"Tuttle","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2026.02.005_bib27","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jaip.2025.03.019","article-title":"Pharmacokinetics and pharmacodynamics of neffy, epinephrine nasal spray, in pediatric allergy patients","volume":"13","author":"Fleischer","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.005_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13601-018-0198-7","article-title":"The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy","volume":"8","author":"Neighbour","year":"2018","journal-title":"Clin Transl Allergy"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826001376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826001376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:58:18Z","timestamp":1776196698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826001376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2213219826001376"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.02.005","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics and Pharmacodynamics Following Repeat Dosing of neffy (Epinephrine Nasal Spray) Versus Intramuscular Injection During Induced Allergic Rhinitis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}